T40.994A Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter

Name of the Condition

• Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter

Summary

This ICD code describes poisoning by other psychodysleptics (hallucinogens) where the intent is undetermined, and it is the initial encounter. It applies to cases involving substances that alter perception, mood, or consciousness, such as mescaline, DMT, or other hallucinogens not classified elsewhere. The code is used when the circumstances of exposure do not clearly indicate accidental, intentional self-harm, or other specified intent, and it is the first time the patient is receiving care for this condition.

Causes

Poisoning may result from exposure to hallucinogens through ingestion, inhalation, or other routes. The undetermined intent suggests that the circumstances of exposure are unclear, such as unknown ingestion, ambiguous self-administration, or unexplained exposure. This could include scenarios where the source or purpose of the substance use is not definitively established during the initial encounter.

Risk Factors

• History of substance use or experimentation.
• Access to hallucinogens in unsecured environments.
• Concurrent use of other psychoactive substances.
• Lack of awareness about the potency or effects of hallucinogens.
• Cognitive impairments affecting judgment or safety awareness.

Symptoms

• Hallucinations, altered perception, or sensory distortions.
• Anxiety, paranoia, or disorientation.
• Nausea, vomiting, or dizziness.
• Increased heart rate or blood pressure.
• Potential for severe psychological distress or confusion.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including patient history, physical examination, and toxicology screening to identify the substance involved. Documentation should note the undetermined intent and the initial nature of the encounter. Clinical judgment is used to assess the circumstances of exposure and rule out other causes of symptoms.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms, and providing supportive care. This may include monitoring vital signs, administering medications to control agitation or nausea, and ensuring a safe environment. In severe cases, hospitalization or intensive care may be necessary. Psychiatric evaluation is often recommended to assess mental health and intent.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, the substance involved, and the patient’s overall health. Most cases resolve with appropriate care, but some may experience prolonged psychological effects. Follow-up care should include monitoring for recurrence, addressing underlying substance use issues, and providing mental health support as needed.

Complications

• Severe psychological distress or psychosis.
• Cardiovascular instability, such as hypertension or tachycardia.
• Respiratory depression or other organ system effects in severe cases.
• Long-term cognitive or psychological sequelae.

Lifestyle & Prevention

• Avoiding use of unknown or unregulated substances.
• Securing medications and substances to prevent accidental exposure.
• Educating about the risks of hallucinogens and their potential for harm.
• Seeking help for substance use concerns or mental health issues.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning are present, such as altered perception, severe anxiety, or physical distress. Prompt care is critical to manage acute effects and prevent complications. Professional help is also recommended for ongoing mental health or substance use concerns.

Tips for Medical Coders

Use this code for the initial encounter of poisoning by other psychodysleptics (hallucinogens) when intent is undetermined. Document the clinical findings, circumstances of exposure, and the initial nature of the encounter to support code assignment. Ensure that the substance is classified as a psychodysleptic (hallucinogen) not elsewhere specified.